NASDAQ: THAR
Tharimmune Inc Stock Forecast, Predictions & Price Target

Analyst price target for THAR

Based on 1 analyst offering 12 month price targets for Tharimmune Inc

Min Forecast
$17.00+1,064.38%
Avg Forecast
$17.00+1,064.38%
Max Forecast
$17.00+1,064.38%

Should I buy or sell THAR stock?

Based on 1 analyst offering ratings for Tharimmune Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their THAR stock forecasts and price targets.

THAR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-12-06

1 of 1

THAR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
THAR$1.46$17.00+1,064.38%Strong Buy
PCSA$0.40$6.00+1,400.00%Buy
ATNF$1.13N/AN/A
APTO$3.48$60.00+1,624.14%Buy
PLRZ$0.54N/AN/A

Tharimmune Stock Forecast FAQ

Is Tharimmune Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: THAR) stock is to Strong Buy THAR stock.

Out of 1 analyst, 1 (100%) are recommending THAR as a Strong Buy, 0 (0%) are recommending THAR as a Buy, 0 (0%) are recommending THAR as a Hold, 0 (0%) are recommending THAR as a Sell, and 0 (0%) are recommending THAR as a Strong Sell.

If you're new to stock investing, here's how to buy Tharimmune stock.

What is THAR's Price Target?

According to 1 Wall Street analyst that have issued a 1 year THAR price target, the average THAR price target is $17.00, with the highest THAR stock price forecast at $17.00 and the lowest THAR stock price forecast at $17.00.

The Wall Street analyst predicted that Tharimmune's share price could reach $17.00 by Dec 6, 2025. The average Tharimmune stock price prediction forecasts a potential upside of 1,064.38% from the current THAR share price of $1.46.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.